Translate Bio

Previously known as RaNA Therapeutics. Translate Bio is a leading biotechnology company focused on pioneering the translation of RNA science into therapeutics promoting healthy gene expression in people living with debilitating genetic diseases. The company’s RNA platforms for powering endogenous therapeutic protein production is applicable to a broad range of diseases including rare diseases of the liver, lung and central nervous system (CNS). For more information about the company, please visit

Latest News Entry
RaNA Therapeutics Secures $55 Million in Oversubscribed Series B Financing

Proceeds will Further Strengthen RaNA’s Proprietary Platform s and Advance Lead Optimization and IND - Enabling Studies for Priority Programs

all portfolio news